Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Unicycive Therapeutics (Nasdaq: UNCY) investors who have lost money should contact Block & Law Firm about ongoing securities fraud investigation.
-
Quoin advances its U.S. patent protection with allowed claims supporting QRX003's investigational approach to treating Netherton Syndrome.
-
Block & Leviton LLP is investigating Primoris Services Corp. for possible securities fraud. Investors should contact Block & Leviton to recover losses.
-
Block & Leviton is investigating Primoris Services ($PRIM) for possible securities law violations. Investors should contact the firm to recover losses.
-
After rigorous evaluation, Bloomberg selects Apptopia to be its flagship mobile data provider on the Terminal.
-
-Designation provides regulatory and development incentives in Japan, including up to 10 years of market exclusivity upon approval- -Follows Orphan Drug Designation, Pediatric Rare Disease...
-
– Filed Breakthrough Medicine Designation Application with Saudi FDA for QRX003 in Netherton Syndrome – Submitted Application to Japanese MHLW for Orphan Drug Designation (ODD) for QRX003; MHLW...
-
Block & Leviton LLP is investigating SoFi Technologies ($SOFI) for possible securities fraud. SOFI Investors should contact the firm to recover losses.
-
Block & Leviton is investigating Check Point Software Technologies Ltd. (Nasdaq: CHKP) for potential securities law violations.
-
Block & Leviton is investigating Driven Brands Holdings, Inc. (Nasdaq: DRVN) for potential securities law violations. Investors should contact the firm.